BrainMap

Andreea Ilioaia Cernat

- UNIVERSITATEA DE MEDICINA SI FARMACIE "IULIU HATIEGANU"

Researcher | Teaching staff | Scientific reviewer

Curriculum Vitae (19/01/2023)

Expertise & keywords

European integration of new technology & socio-economic solutions for increasing consumer trust and engagement in seafood products Call name: P 5.8 - SP 5.8.1 - Premiere Orizont Europa - Instituții - Competiția 2023
PN-IV-P8-8.1-PRE-HE-ORG-2023-0076 2023 - 2025

Role in this project:

Coordinating institution: UNIVERSITATEA DE MEDICINA SI FARMACIE "IULIU HATIEGANU"

Project partners: UNIVERSITATEA DE MEDICINA SI FARMACIE "IULIU HATIEGANU" (RO)

Affiliation:

Project website:

Abstract:

FishEUTrust represents a consortium of twenty-two organizations from fourteen countries, pooling their expertise to defragment the current food system to ensure sustainability and deliver solutions for a transparent and traceable seafood supply chain necessary to promote high-end, pan-European farmed seafood. The innovation at the heart of FishEUTrust is integrating different actors into a digital platform that links technology providers, supply chain stakeholders, regulatory/policymakers and consumers. FishEUTrust will establish five Co-creation Living Labs (CLLs) in diverse environments: the Mediterranean Basin, the North Sea and the Atlantic Sea.

These CLLs will enable user involvement in innovation and development processes and act as demonstrators for the consortium to test and validate digital and non-digital supply chain solutions. Examples include creating sustainable business models, exploiting IPR

strategies for aquaculture, e.g., protecting cultural and culinary heritage, short food supply chains, exploiting underused fish species, and innovative engaging activities to stimulate/nudge behavioural change. It will also develop tools for maximizing trust by

guaranteeing the quality, safety, and traceability of seafood products based on smart control systems (sensors), a suite of tools integrating metagenomics, genetic biomarkers, isotopic techniques, and digital technologies (labelling, Product Passport/

Blockchain). These tools will be integrated into a single cutting-edge digital FishEUTrust platform that will apply the latest in artificial intelligence, data science and human-computer interactions. Finally, an integrated impact assessment and life cycle analysis will be performed to quantify the environmental footprint, health sustainability, and socio-economic benefits of FishEUTrust solutions.

FishEUTrust will be supported by a comprehensive scientific, public, policymaker and industrial dissemination plan to communicate results to a broad audience.

Nanoplatforms for the rapid electrochemical detection of Staphylococcus aureus by specific markers Call name: P 1 - SP 1.1 - Proiecte de cercetare pentru stimularea tinerelor echipe independente - TE-2021
PN-III-P1-1.1-TE-2021-0846 2023 - 2024

Role in this project:

Coordinating institution: UNIVERSITATEA DE MEDICINA SI FARMACIE "IULIU HATIEGANU"

Project partners: UNIVERSITATEA DE MEDICINA SI FARMACIE "IULIU HATIEGANU" (RO)

Affiliation:

Project website: https://sites.google.com/view/starsens/home

Abstract:

Staphylococcus aureus (S. aureus) is a dangerous pathogenic agent responsible of many diseases, from mild to life-threatening ones, frequently causing healthcare-associated infections. Knowing the high risks that pathogens pose and their resistance to antibiotics, it is crucial to develop new methods for their early real-time detection to be able to initiate therapy and prevent severe complications. Electrochemical sensors emerged as alternatives to conventional methods (microbiological culture, ELISA, PCR) due to their advantages: high sensitivity and selectivity simplicity, low cost, short analysis time, robustness, possibility for portability (suitable for point-of-use/care devices). The purpose of StarSens is represented by the development of new strategies for rapid diagnosis of S. aureus infection through the electrochemical detection of Staphyloferrin A and Protein A, as specific markers. The project has several goals: (1) Development of nanostructured surfaces for the direct electrochemical detection of Staphyloferrin A, siderophore of S. aureus; (2) Development of an aptasensor for Protein A; (3) Evaluation of the (apta)sensors in real samples (human serum, real samples from volunteers, and culture plates). The foreseen results will contribute to advancing the know-how in the biomedical and analytical chemistry fields offering new perspectives for the development of novel (bio)sensors and methods applicable for microbiology diagnosis and therapeutic monitoring.

Wearable electrochemical sensors for the non-invasive detection of inflammatory mediators expressed in post-COVID-19 condition Call name: P 1 - SP 1.1 - Proiecte de cercetare pentru stimularea tinerelor echipe independente - TE-2021
PN-III-P1-1.1-TE-2021-1543 2022 - 2024

Role in this project:

Coordinating institution: UNIVERSITATEA DE MEDICINA SI FARMACIE "IULIU HATIEGANU"

Project partners: UNIVERSITATEA DE MEDICINA SI FARMACIE "IULIU HATIEGANU" (RO)

Affiliation:

Project website: https://wear-4-postcovaid.wixsite.com/wearable

Abstract:

Post-COVID-19 condition is characterized by a wide range of symptoms that may last more than 24 weeks after the onset of the infection, with high socio-economic impact. According to WHO, research on predictors for post-COVID-19 condition is of paramount importance to provide new strategies for minimizing SARS-CoV-2 post-infection consequences. The theme of WEAR-4-postCOVaID is very important, aiming for the validation of a panel of different types of biomarkers: interleukin 6, tumour necrosis factor-α, cortisol and kynurenic acid that can be used to early predict medical complications and to monitor patients’ rehabilitation after SARS-CoV-2 infection. The purpose of WEAR-4-postCOVaID is to develop a device for the rapid detection of biomarkers expressed in post-COVID-19 syndrome as a tool for medical staff for easier diagnosis and monitoring of patients. Deepening the knowledge about post-COVID-19 condition (1) and finding the interconnection between biomarkers levels in different body fluids and the main symptoms of this medical condition (2) are the goals of the project with specific and interconnected objectives. The originality of the project consists in the elaboration of innovative electrochemical sensors for the salivary detection of the four biomarkers, the correlation between the levels of the biomarkers (IL-6 and cortisol) in saliva and sweat, and the development of a dual wearable sensor for monitoring their levels in sweat with biomedical applications.

Border detection of illicit drugs and precursors by highly accurate electrosensors Call name:
833787 2019 - 2023

Role in this project: Key expert

Coordinating institution: University of Antwerp

Project partners: University of Antwerp (RO); UNIVERSITATEA DE MEDICINA SI FARMACIE "IULIU HATIEGANU" (RO)

Affiliation: UNIVERSITATEA DE MEDICINA SI FARMACIE "IULIU HATIEGANU" (RO)

Project website: http://www.bordersens.eu

Abstract:

Combining robust sensor technologies with the inherent advantages of electrochemical strategies, nano-molecularly imprinted polymers, and multivariate and pattern data analysis, BorderSens will enable highly accurate selective detection of trace levels of illicit drugs and precursors. With borders being important gateways for the entrance of illicit drugs and their precursors, custom and border control authorities are facing pertaining challenges to detect such dangerous substances and safeguard the public. The main challenges posed by currently used on-site methods to detect illicit drugs and precursors are low accuracy, in the case of colour tests, and high cost and low portability, in the case of spectroscopic tests. In the light of a pressing need for better drug test systems at EU borders, the ultimate research aim of the BorderSens is to develop a portable, wireless single prototype device with the capability to quickly test for different types of drugs, precursors and adulterants/cutting agents, with outstanding accuracy and reduced false positives and false negatives. BorderSens will demonstrate the innovative technological solutions at seven demonstrations sites at EU borders with end-users and ensure exploitation plans guaranteeing strong impact. BorderSens brings together universities, a big manufacturer of electrochemical sensors, a specialised SME, ten end-users i.e. forensic institutes, police forces and border authorities, and a high quality external advisory board, to provide an excellent scientific-technical perspective and a straightforward exploitation route, with great impact on the safety of EU citizens.

Pathogen Contamination Emergency Response Technologies Call name: EC - H2020
H2020-229396-883484 2020 - 2023

Role in this project: Key expert

Coordinating institution: UNIVERSITY OF CYPRUS

Project partners: UNIVERSITY OF CYPRUS (CY); ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS (EL); WATER EUROPE (BE); COMMUNICATION AND INFORMATION SYSTEMS DIRECTORATE (BG); AQUA-Q AB (SE); KWR WATER B.V. (NL); ETAIRIA HYDREFSIS KAI APOCHETEFSIS THESSALONIKIS AE (EL); SUNDOSOFT LTD (KR); UNIVERSITATEA DE MEDICINA SI FARMACIE IULIU HATIEGANU CLUJ-NAPOCA (RO); MINISTRY OF INTERIOR (CY); Korea Institute of Science and Technology (KR); ELLINIKI OMADA DIASOSIS SOMATEIO (EL); NATIONAL TECHNICAL UNIVERSITY OF ATHENS - NTUA (EL); MicroLAN (NL); CETAQUA, CENTRO TECNOLOGICO DEL AGUA, FUNDACION PRIVADA (ES); AYUNTAMIENTO DE GRANADA (ES); FUNDACIO EURECAT (ES); SATWAYS - PROIONTA KAI YPIRESIES TILEMATIKIS DIKTYAKON KAI TILEPIKINONIAKON EFARMOGON ETAIRIA PERIORISMENIS EFTHINIS EPE (EL); COLLABORATING CENTRE ON SUSTAINABLE CONSUMPTION AND PRODUCTION GGMBH (DE); STICHTING WATERNET (NL); FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE); PHOEBE RESEARCH AND INNOVATION LTD (CY); ENGINEERING - INGEGNERIA INFORMATICA SPA (IT); FUNDACION CENTRO ANDALUZ DE INVESTIGACIONES DEL AGUA (ES); EMPRESA MUNICIPAL DE ABASTECIMIENTO Y SANEAMIENTO DE GRANADA SA (ES); UNIVERSITY OF STUTTGART (DE); LABAQUA SA (ES)

Affiliation: UNIVERSITATEA DE MEDICINA SI FARMACIE IULIU HATIEGANU CLUJ-NAPOCA (RO)

Project website:

Abstract:

Border detection of illicit drugs and precursors by highly accurate electrosensors Call name: P 3 - SP 3.6 - Premierea participării în Orizont 2020
PN-III-P3-3.6-H2020-2020-0095 2020 - 2022

Role in this project:

Coordinating institution: UNIVERSITATEA DE MEDICINA SI FARMACIE "IULIU HATIEGANU"

Project partners: UNIVERSITATEA DE MEDICINA SI FARMACIE "IULIU HATIEGANU" (RO)

Affiliation:

Project website: https://bordersens.eu/

Abstract:

Combining robust sensor technologies with the inherent advantages of electrochemical strategies, nano-molecularly imprinted polymers, and multivariate and pattern data analysis, BorderSens will enable highly accurate selective detection of trace levels of illicit drugs and precursors. With borders being important gateways for the entrance of illicit drugs and their precursors, custom and border control authorities are facing pertaining challenges to detect such dangerous substances and safeguard the public. The main challenges posed by currently used on-site methods to detect illicit drugs and precursors are low accuracy, in the case of colour tests, and high cost and low portability, in the case of spectroscopic tests. In the light of a

pressing need for better drug test systems at EU borders, the ultimate research aim of the BorderSens is to develop a portable, wireless single prototype device with the capability to quickly test for different types of drugs, precursors and adulterants/cutting agents, with outstanding accuracy and reduced false positives and false negatives. BorderSens will demonstrate the innovative technological solutions at seven demonstrations sites at EU borders with end-users and ensure exploitation plans guaranteeing strong impact. BorderSens brings together universities, a big manufacturer of electrochemical sensors, a specialised SME, ten end-users i.e. forensic institutes, police forces and border authorities, and a high quality external advisory board, to provide an excellent scientific-technical perspective and a straightforward exploitation route, with great impact on the safety of EU citizens.

Electrochemical detection of bacterial quorum sensing molecules and biofilm formation Call name: P 1 - SP 1.1 - Proiecte de cercetare pentru stimularea tinerelor echipe independente
PN-III-P1-1.1-TE-2019-1360 2020 - 2022

Role in this project:

Coordinating institution: UNIVERSITATEA DE MEDICINA SI FARMACIE "IULIU HATIEGANU"

Project partners: UNIVERSITATEA DE MEDICINA SI FARMACIE "IULIU HATIEGANU" (RO)

Affiliation: UNIVERSITATEA DE MEDICINA SI FARMACIE "IULIU HATIEGANU" (RO)

Project website: https://sites.google.com/view/quorel-sens/home

Abstract:

Quorum sensing (QS) plays an important role in the pathogenesis of certain bacteria due to its involvement in virulence factors synthesis and formation of the biofilm, which is resistant to the immune system and to antibiotics. QS is a form of cell to cell communication between bacteria using substances called autoinducers, such as N-acyl derivatives of homoserine lactone (HSLs) or cyclic dimeric guanosine monophosphate (c-di-GMP), the latter being involved in biofilm formation.

The main purpose of this project consists in facilitating the fast identification of nosocomial infections and their proper antibiotic treatment, by electrochemical detection of molecules involved in QS and biofilm formation from microbiological cultures and different biological samples.

The QUOREL-SENS project includes several goals: development of a global strategy for obtaining electrochemical biomimetic sensors capable of (1) selective and sensitive detection of QS in P. aeruginosa, (2) of the biofilm formed by P. aeruginosa, and of (3) simultaneous electrochemical evaluation of the concentration of QS molecules or biofilm formation and the concentration of different antibiotics.

The envisioned goals will be achieved by two different, interconnected strategies, with specific objectives: (1) modification of the electrodes with molecularly imprinted polymers (improving the selectivity) and with nanomaterials (improving the electrochemical properties and the sensitivity) for the detection of HSLs and of c-di-GMP produced by P. aeruginosa; (2) development of electrochemical aptasensors for the detection of HSLs and of c-di-GMP; (3) evaluation of the concentration of molecules involved in QS or biofilm formation in the presence of different antibiotics, their concentration being detected electrochemically before and after exposure to antibiotics; (4) complete characterization of the developed electrochemical sensors and their adaptation for real samples analysis.

Smart materials for medical applications Call name: P 1 - SP 1.2 - Proiecte complexe realizate in consorții CDI
PN-III-P1-1.2-PCCDI-2017-0407 2018 - 2021

Role in this project:

Coordinating institution: UNIVERSITATEA POLITEHNICA DIN BUCURESTI

Project partners: UNIVERSITATEA POLITEHNICA DIN BUCURESTI (RO); CENTRUL DE CHIMIE ORGANICA AL ACADEMIEI ROMANE "C.D.NENITESCU" (RO); UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA" (RO); UNIVERSITATEA BUCURESTI (RO); INSTITUTUL NATIONAL DE CERCETARE - DEZVOLTARE CHIMICO - FARMACEUTICA - I.C.C.F. BUCURESTI (RO); Institutul National de Cercetare-Dezvoltare pentru Chimie si Petrochimie - ICECHIM Bucuresti (RO); UNIVERSITATEA DE MEDICINA SI FARMACIE "GRIGORE T. POPA" DIN IAŞI (RO); INSTITUTUL NATIONAL DE CERCETARE DEZVOLTARE PENTRU FIZICA LASERILOR, PLASMEI SI RADIATIEI - INFLPR RA (RO); UNIVERSITATEA DE MEDICINA SI FARMACIE "IULIU HATIEGANU" (RO)

Affiliation: UNIVERSITATEA DE MEDICINA SI FARMACIE "IULIU HATIEGANU" (RO)

Project website: https://intelmatupb.wixsite.com/intelmat

Abstract:

INTELMAT project represents advanced research in the field of synthesis and application of smart materials for medical engineering in order to solve essential features of some acute/chronic diseases of large occurrence. 5 thematic directions are taking into consideration: 1. Developing of a controlled-release system of complex micro-colloidal architectures based on bacterial cellulose and hydrogels used for management of chronically wounds which aims to overcome the limitations of classical treatments; 2. Developing of new biomaterials specially designed with targeted action for treatment of inflammatory diseases of gastrointestinal segment; 3. Synthesis of new generation of composite membrane materials for artificial kidneys based on biocompatible polymers and derivative graphene; 4. Developing of some auto-assembly 3D platforms with controlled-released drugs based on polymeric nanoparticles and composite nanogels for the therapy of colon-rectal cancer; 5. Developing of innovative technologies for the synthesis of some 1D nano-architectures (nanowires) with controlled morphology, with applications in producing of non-enzimatic electrochemical biosensors.

High accuracy innovative approach for the robotic assisted intraoperatory treatment of hepatic tumors based on imagistic-molecular diagnosis Call name: P 1 - SP 1.2 - Proiecte complexe realizate in consorții CDI
PN-III-P1-1.2-PCCDI-2017-0221 2018 - 2021

Role in this project:

Coordinating institution: UNIVERSITATEA TEHNICA DIN CLUJ - NAPOCA

Project partners: UNIVERSITATEA TEHNICA DIN CLUJ - NAPOCA (RO); UNIVERSITATEA DE MEDICINA SI FARMACIE "IULIU HATIEGANU" (RO); INSTITUTUL DE MECANICA SOLIDELOR (RO); INSTITUTUL REGIONAL DE GASTROENTEROLOGIE - HEPATOLOGIE PROF. DR. OCTAVIAN FODOR CLUJ-NAPOCA (RO); INSTITUTUL NATIONAL DE CERCETARE-DEZVOLTARE PENTRU OPTOELECTRONICA INOE 2000 INCD (RO)

Affiliation: UNIVERSITATEA DE MEDICINA SI FARMACIE "IULIU HATIEGANU" (RO)

Project website: https://cester.utcluj.ro/improve/home

Abstract:

The IMPROVE project will be developed by a transdisciplinary group, which integrates the knowledge of multiple specialists from the technical field (such as mechanical engineers, computer science engineers and material sciences engineers), a team of medical doctors (surgeons, gastroenterologists, oncologists, and radiologists), and a team of chemical scientists. The IMPROVE group will develop an innovative solution for the treatment of the patients diagnosed with non resectable hepatic tumors, based on a novel robotic system, and an novel medical imaging diagnostic tool. The majority of the hepatic tumors are not resectable due to a variety of factors such as tumor placement, size, and the patient general condition. In order to deliver a better palliative care towards the patient, and a better quality of life, the IMPROVE project proposes an integrated system to deliver treatment in the form of brachytherapy or chemotherapy. The treatment will be delivered in a minimally invasive manner, guided by a robot (which delivers the treatment agent through needles), based with a non-invasive diagnostic method. The diagnosis stage consists of the development of “smart” image analysis algorithms which can detect and define some hepatic diseases such as cancers. The preplanning stage will define the treatment method as well as the needle trajectories. For the treatment delivery a robotic structure will be developed to help the clinicians in the minimally invasive (laparoscopic) in situ procedure. The treatment agent (brachytherapy of chemotherapy) will be precisely delivered within the tumor using specialized instruments (for needle insertion and delivery) guided by the robotic system. The IMPROVE team is composed out of experienced researchers whit excellent results in the medical field, and well based former collaborations. The group synergy represents a key factor in obtaining positive results in the survival outcome of the hepatic cancer patients.

Design sensing platforms for detection and quantification of biomarkers involved in neurological disorders Call name: Projects for Young Research Teams - RUTE -2014 call
PN-II-RU-TE-2014-4-0460 2015 - 2017

Role in this project:

Coordinating institution: UNIVERSITATEA DE MEDICINA SI FARMACIE (U.M.F) Cluj-Napoca

Project partners: UNIVERSITATEA DE MEDICINA SI FARMACIE (U.M.F) Cluj-Napoca (RO)

Affiliation: UNIVERSITATEA DE MEDICINA SI FARMACIE (U.M.F) Cluj-Napoca (RO)

Project website: http://www.granturi.umfcluj.ro/BIO-NEURO-SENS

Abstract:

Neurological disorders are numerous, diverse, frequently severe, affecting a large portion of the world’s population, with challenges in their diagnosis and treatment. The current project proposes the development of a global strategy for designing (bio)sensors, involving an ultrasensitive electrochemical setup based on a specific and selective nanoplatform capable of simultaneous detection of some biomarkers involved in neurological disorders. The originality of the proposed project resides from the use of electroanalytical methods involving electrodes modified in a controlled and optimized way with a novel association of nanomaterials with bioelements. Various strategies are envisaged for the functionalization of different types of electrodes and the use of various nanomaterials, design of new and innovative way that will allow their immobilization. The obtainment of the completely functional nanoplatforms will be followed by the optimum immobilization of the bioelements (enzyme, antibody, aptamer) will be determined, assuring highly specific detection. After the complete characterization of the elaborated sensors in terms of properties and performances, their application for real samples analyses will be tested, as a first step in development of point-of-care devices.

The success of the project could assure an early diagnosis of neurological disorders with improvement in the health of the population.

AMPEROMETRIC IMMUNOSENSOR FOR OVARIAN AND UTERINE CANCER BIOMARKERS Call name: Exploratory Research Projects - PCE-2011 call
PN-II-ID-PCE-2011-3-0355 2011 - 2016

Role in this project:

Coordinating institution: Universitatea de Medicina si Farmacie ˝Iuliu Hatieganu˝ Cluj-Napoca

Project partners: Universitatea de Medicina si Farmacie ˝Iuliu Hatieganu˝ Cluj-Napoca (RO)

Affiliation:

Project website: http://www.granturi.umfcluj.ro/id338

Abstract:

The MUC1 gene encodes a type-I transmembrane glycoprotein that is expressed on the apical surface of most simple epithelia, including mammary gland, female reproductive tract, lung, kidney, stomach, gall bladder, and pancreas as well as some non-epithelial cell types.

Recent immunological studies suggest that MUC1 is a potential marker and a prognosis factor in diagnosis of ovarian cancer and endometriosis.

It is proposed the elaboration of a novel series of immunosensors based on MUC1 and tumor MUC1 proteins, which can be a specific and sensitive alternative to currently more or less invasive, immunohistochemical methods actually used. Once the tumor proteins in blood successfully detected, will be followed by the design and construction of a noninvasive, specific and sensitive diagnostic device for biological fluids.

The main objectives are: 1). Development of new immunosensing devices; a. Electroactive surface design (fabrication of gold and carbon based screen-printed electrodes functionalized by thiolic compounds, carbon nanotubes, graphenes as nanobiolabels); b. Bioelement design (choice of antibodies and/or aptamers); c. Immunosensor development by different immobilization methods (biotin-avidin, selfassembling, conducting polymers); 2). Electroanalytical characterization of the new immunosensors (electrode surface characterization, electroanalytical performances); 3). Immunoelectrochemical method elaboration and prevalidation (design and optimization of the immun

FUNCTIONALIZED NANOMATERIALS WITH CHROMO AND FLUOROPHORES AND NANOSTRUCTURED PLATFORMS FOR BIOSENSORS APPLIED IN PHARMACEUTICAL AND BIOMEDICAL FIELDS Call name: Programul de actiuni Integrate Romania-Franta (bilaterale)
PN-II-CT-RO-FR-2014-2-0008 2014 -

Role in this project:

Coordinating institution: UNIVERSITATEA DE MEDICINA SI FARMACIE (U.M.F) Cluj-Napoca

Project partners: UNIVERSITATEA DE MEDICINA SI FARMACIE (U.M.F) Cluj-Napoca (RO); Universite Joseph Fourier (FR)

Affiliation: UNIVERSITATEA DE MEDICINA SI FARMACIE (U.M.F) Cluj-Napoca (RO)

Project website:

Abstract:

The aim of this project is to obtain supramolecular nanomaterials functionalized with chromophores and fluorescent compounds and nanostructured platform for the development of biosensors with possible applications in the detection of biomedical and pharmaceutical compounds. For this purpose new nanostructured surfaces with photoelectrochemical properties will be develop by combining chromophores or fluorophores with new nanomaterials. Several molecules are taken into account: photosensitive transition metal complexes such as complexes of Ru(II) with pyridine having photoelectrochemical and electrochemiluminescence properties, and tetrazine derivatives, due to their fluorescent properties. Another objective of the project is to obtain nanostructured platforms by nanospheric lithography for the controlled immobilization of biomolecules and rational design of biosensors, with possible applications in biomedical analysis. Modified electrodes with graphene, cyclodextrins and polymer films for detection and simultaneous determination of ascorbic acid, uric acid and dopamine in pharmaceutical and biological samples will also develop. This collaboration will enable the development of new research directions on the topic of biosensors using the scientific skills of each team.

FILE DESCRIPTION	DOCUMENT
List of research grants as project coordinator or partner team leader
Significant R&D projects for enterprises, as project manager
R&D activities in enterprises
Peer-review activity for international programs/projects